Open Clinical Evaluation of Siddha Polyherbal Formulatiom Gowthamar Chooranam for Swasakasam( Bronchial Asthma)

Phase II Non-Randomized Open Clinical Evaluation of Siddha Polyherbal Formulatiom Gowthamar Chooranam for Swasakasam( Bronchial Asthma)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/11/047182

Enrollment

Registered

2022-11-10

Start date

Unknown

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J453- Mild persistent asthma

Interventions

Intervention1: Gowthamar chooranam: Siddha Polyherbal formulation Dose 1gram bd with honey or ghee after food for 48 days Intervention2: GOWTHAMAR CHOORANAM: SIDDHA POLYHERBAL FORMULATION Control Inte

Eligibility

Inclusion criteria

Inclusion criteria: Cough with tenacious sputum Dyspnoea H/O Wheeze or without wheeze Chest tightness Post covid

Exclusion criteria

Exclusion criteria: Chronic bronchitis Bronchiectasis Bronchogenic carcinoma Pulmonary TB Congestive cardiac failure Pregnancy and lactating mothers Status asthmaticus Diabetes mellitus

Design outcomes

Primary

Measure	Time frame
Primary outcome is mainly assessed by reduction in clinical symptoms like wheeze, dyspnoea and chest tightness after treatment.Timepoint: 4 weeks	—

Secondary

Measure	Time frame
Assessing peak expiratory flow rate above 60% ensures the wellness of the patient.Timepoint: 48 weeks	—

Countries

India

Contacts

Public ContactM Anitha kalaivani

Government Siddha Medical College

chittu758@gmail.com9444177230

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026